High insulin prices are leaving some people who need the drug without access. Erik McGregor/LightRocket via Getty Images May 9, 2022 Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes Jing Luo, University of Pittsburgh About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
Miniature biomanufacturing kits like this prototype could revolutionize the pharmaceutical industry. Amino Labs September 13, 2018 After a century, insulin is still expensive – could DIYers change that? Jenna E. Gallegos, Colorado State University and Jean Peccoud, Colorado State University Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
The cells inside this bioreactor are the real pharmaceutical factories. Sanofi Pasteur July 25, 2017 Biologics: The pricey drugs transforming medicine Ian Haydon, University of Washington Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here’s where they come from and how they work.